ISSN 1674-3865  CN 21-1569/R
主管:国家卫生健康委员会
主办:中国医师协会
   辽宁省基础医学研究所
   辽宁中医药大学附属医院

中国中西医结合儿科学 ›› 2018, Vol. 10 ›› Issue (4): 295-297.doi: 10.3969/j.issn.1674-3865.2018.04.006

• 临床研究 • 上一篇    下一篇

小儿智力糖浆治疗儿童抽动障碍的临床疗效观察

孔敏,郝爱青,陈丙涛,任立中   

  1. 273100 山东 曲阜,曲阜市中医院儿科
  • 出版日期:2018-08-25 发布日期:2018-12-03
  • 通讯作者: 孔敏,E-mail:mibo20080318@yeah.net
  • 作者简介:孔敏(1978-),女,医学博士,主治医师。研究方向:小儿神经系统疾病的诊治
  • 基金资助:
    2016年山东省济宁市中医药科技项目(zyy2016-21)

Clinical effect of Children's Intelligence syrup for tic disorders

KONG Min, HAO Aiqing, CHEN Bingtao, REN Lizhong   

  1. Qufu Hospital of Traditional Chinese Medicine of Shandong Province, Qufu 273100, China
  • Online:2018-08-25 Published:2018-12-03

摘要:
目的
观察小儿智力糖浆治疗儿童短暂性抽动障碍的临床疗效。
方法
收集2016年7月至2018年2月曲阜市中医院儿科诊治的短暂性抽动障碍患儿60例为研究对象,随机分为观察组和对照组各30例。观察组给予口服小儿智力糖浆治疗,对照组给予口服盐酸硫必利治疗,两组均治疗3个月为1个疗程。根据耶鲁抽动严重程度量表,从抽动的数目、频率、强度、复杂性和干扰5个维度对患儿进行临床疗效评估;根据治疗副反应积分量表进行药物安全性评价。
结果
同组治疗前后耶鲁抽动障碍整体严重度量表总积分比较,差异有统计学意义(P<0.05);治疗后两组耶鲁抽动障碍整体严重度量表积分比较,差异无统计学意义(P>0.05)。两组患儿治疗总有效率比较,差异无统计学意义(P>0.05)。观察组患儿治疗副反应积分为(2.05±0.18)分,显著低于对照组(13.55±4.82)分,差异有统计学意义(P<0.05)。观察组不良反应主要表现为轻微的胃肠道反应,对照组不良反应主要表现为嗜睡、头晕、恶心、学习成绩下降等。
结论
小儿智力糖浆治疗儿童抽动障碍疗效确切,且不良反应轻微,可在临床推广应用。

关键词: 抽动障碍, 小儿智力糖浆, 临床研究, 儿童

Abstract:
Objective:
To observe the clinical efficacy of Children's Intelligence syrup in the treatment of children with transient tic disorders.
Methods:
A total of 60 children with transient tic disorders were included in the study, who visited in the Pediatric Department of Qufu Hospital of Traditional Chinese Medicine between Jul. 2016 and Feb. 2018, and they were randomly divided into experimental group and control group, with 30 children in each group. The experimental group took Children's Intelligence syrup orally, and the control group took tiapride hydrochloride orally. Two groups were treated for 3 months as a course. The clinical efficacy was evaluated by Yale Globe Tic Severity Scale(YGTSS) with 5 dimensional scores (number, frequency, intensity, complexity and interference). The drug safety was evaluated by Treatment Emergent Symptom Scale(TESS).
Results:
The total scores of YGTSS of two groups after treatment were significantly lower than those before treatment, there being statistical difference(P<0.05). The total scores of YGTSS of the experimental group were similar to those of the control group after treatment, and the difference was not statistically significant(P>0.05). The total effective rate of two groups was similar, the difference being not statistically significant(P>0.05). The total scores of TESS of the experimental group (2.05±0.18) were significantly lower than those of the control group(13.55±4.82), there being statistical difference(P<0.05).The main adverse reactions in experimental group were mild gastrointestinal reactions and those in control group were drowsiness, dizziness, nausea and worse school performance.
Conclusion:
Children's Intelligence syrup has significant effect in the treatment of children with tic disorders, which has fewer adverse reactions and higher safety, so it is worth the clinical promotion and application.

Key words: Tic disorders, Children's Intelligence syrup, Clinical study, Children